Contrasting Moolec Science (NASDAQ:MLEC) and Thunder Bridge Capital Partners IV (NASDAQ:THCP)

Thunder Bridge Capital Partners IV (NASDAQ:THCP) and Moolec Science (NASDAQ:MLEC) are both small-cap unclassified companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

Insider & Institutional Ownership

33.2% of Thunder Bridge Capital Partners IV shares are held by institutional investors. Comparatively, 0.1% of Moolec Science shares are held by institutional investors. 65.1% of Thunder Bridge Capital Partners IV shares are held by company insiders. Comparatively, 19.9% of Moolec Science shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Thunder Bridge Capital Partners IV and Moolec Science’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Thunder Bridge Capital Partners IV	N/A	-15.04%	-0.48%
Moolec Science	-129.97%	-93.88%	-33.37%

Analyst Recommendations

This is a breakdown of current recommendations for Thunder Bridge Capital Partners IV and Moolec Science, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Thunder Bridge Capital Partners IV	0	0	0	0	N/A
Moolec Science	0	0	1	0	3.00

Moolec Science has a consensus price target of $6.00, suggesting a potential upside of 552.17%. Given Moolec Science’s higher possible upside, analysts plainly believe Moolec Science is more favorable than Thunder Bridge Capital Partners IV.

Earnings & Valuation

This table compares Thunder Bridge Capital Partners IV and Moolec Science”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Thunder Bridge Capital Partners IV	N/A	N/A	$4.09 million	N/A	N/A
Moolec Science	$5.63 million	6.14	-$7.31 million	($0.20)	-4.60

Thunder Bridge Capital Partners IV has higher earnings, but lower revenue than Moolec Science.

Summary

Thunder Bridge Capital Partners IV beats Moolec Science on 6 of the 9 factors compared between the two stocks.

About Thunder Bridge Capital Partners IV

Thunder Bridge Capital Partners IV Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Great Falls, Virginia.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.